Pfizer Newsroom

Pfizer (PFE) Gets a Hold From J.P. Morgan

TipRanks03:57 ET

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating, Announces Target Price $28

Moomoo News03:31 ET

Cautious Outlook: Pfizer's EPS Downgrade and Conservative Guidance Prompt Hold Rating

TipRanks02:08 ET

Pfizer Is Maintained at Buy by Guggenheim

Dow Jones11:59 ET

Pfizer Analyst Ratings

Benzinga11:54 ET

Guggenheim Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33

Moomoo NewsDec 11 09:31 ET

Evercore Maintains Pfizer(PFE.US) With Buy Rating

Moomoo NewsDec 11 08:31 ET

Pfizer (PFE) Gets a Buy From Evercore ISI

TipRanksDec 11 08:18 ET

Guggenheim Adjusts Price Target on Pfizer to $33 From $35, Keeps Buy Rating

MT NewswiresDec 11 05:47 ET

Pfizer Analyst Ratings

BenzingaDec 10 07:44 ET

B of A Securities Reinstates Neutral on Pfizer, Announces $29 Price Target

BenzingaDec 10 07:43 ET

Berenberg Bank Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $29

Moomoo NewsNov 29 09:31 ET

Berenberg Bank Sticks to Their Hold Rating for Pfizer (PFE)

TipRanksNov 29 09:00 ET

Morgan Stanley Sticks to Their Hold Rating for Pfizer (PFE)

TipRanksNov 25 10:31 ET

Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31

Moomoo NewsNov 25 10:31 ET

Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating

Moomoo NewsNov 20 13:31 ET

Wolfe Research Initiates Pfizer at Underperform With $25 Price Target

MT NewswiresNov 15 06:05 ET

Pfizer Analyst Ratings

BenzingaNov 15 05:57 ET

Wolfe Research Downgrades Pfizer(PFE.US) to Sell Rating, Announces Target Price $25

Moomoo NewsNov 14 16:30 ET

Pfizer Initiated With an Underperform at Wolfe Research

TipRanksNov 14 16:25 ET